Drug Shortage Report for APPRILON
Report ID | 222034 |
Drug Identification Number | 02375885 |
Brand name | APPRILON |
Common or Proper name | DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) |
Company Name | GALDERMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DOXYCYCLINE |
Strength(s) | 40MG |
Dosage form(s) | CAPSULE (IMMEDIATE AND DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 2 14-capsule blister cards (28 capsules) |
ATC code | J01AA |
ATC description | TETRACYCLINES |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-03-13 |
Actual start date | 2024-03-13 |
Estimated end date | 2024-03-22 |
Actual end date | 2024-03-19 |
Shortage status | Resolved |
Updated date | 2024-03-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 COMMERCE VALLEY DRIVE WEST THORNHILL, ONTARIO CANADA L3T 7V9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-03-20 | English | Compare |
v6 | 2024-03-19 | French | Compare |
v5 | 2024-03-19 | English | Compare |
v4 | 2024-03-14 | English | Compare |
v3 | 2024-03-13 | French | Compare |
v2 | 2024-03-13 | English | Compare |
v1 | 2024-03-13 | English | Compare |
Showing 1 to 7 of 7